MTS Medication Technologies Corporate Finance Deal

Deals

	Tombstones: Merger, Acquisition, and Divestiture Projects
	Tombstones: Corporate Finance Projects
	Tombstones: Strategic Partnering Projects
	Testimonials

Middle Market Topical Index
	Middle market investment bank
	Why middle market companies choose FOCUS
	Middle market M&A
	Middle market divestitures
	Middle market corporate finance
	Middle market advisor services
	Middle market strategic partnering
	Middle market corporate development

This announcement appears as a matter of record only

MTS Medication Technologies

Received $13,000,000 for working capital from

LaSalle Bank and Berwind Growth Capital

FOCUS Partner James C. Harper assisted in the negotiations as the representative of MTS Medication Technologies.

Complimentary,
middle market monthly email newsletter. Relevant insights, trends, and news. Substance, not fluff.
more information....

Read more about FOCUS Enterprises' various business sector experience... Read More

Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker dealer and member FINRA/SIPC.